Damian Wild

17PUBLICATIONS
33CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Neurosciences not elsewhere classifiedTime-series analysisMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 11, 2026
Radiolabelled somatostatin receptor antagonist versus agonist for peptide receptor radionuclide therapy in patients with metastatic pheochromocytoma or paraganglioma: a retrospective pilot study.

|May 21, 2026
68Ga-DOTA-exendin-4 PET/CT for Insulinoma Localization in Patients with Negative or Inconclusive Conventional Imaging.

|May 04, 2026
Clinical Outcomes of Peptide Receptor Radionuclide Therapy in Japanese Patients with Metastatic Rectal Neuroendocrine Tumors.

|Mar 17, 2026
Temporal trends in pretest probability and normal scan rates in myocardial perfusion imaging: a 24-year experience from a Swiss tertiary referral center (between 2000 and 2024).

Simon M Frey, Igor G Schneider, Ann-Sophie Otto

|Aug 01, 2025
Exenatide for diagnosing endogenous hyperinsulinemic hypoglycemia: a randomized placebo-controlled, double-blind, cross-over proof-of-principle study.

Matthias Hepprich, Christina Romberg, Jonathan Mudry

|Jul 24, 2025
Congenital Hyperinsulinemic Hypoglycemia With a New HADH Mutation and Pancreatic Overexpression of GLP-1 Receptors.

Andrea Widmer, Urs Zumsteg, Gabor Szinnai

Pageof 3

Frequent Collaborators

4 joint publications

Emanuel Christ

2 joint publications

Philip Haaf

2 joint publications

Simon M Frey

2 joint publications

Julie Refardt